Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07194928 · ClinicalTrials.gov registry record
Medical Cannabis as an Opiate Alternative
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 29
- Enrollment target
NCT07194928: Completed study, sponsored by University of Pennsylvania.
NCT07194928 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 29 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07194928 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
Medical Cannabis is very safe and a viable option for pain relief to improve patients and their family's quality of life. However, medical cannabis is not covered by insurance and is an out of pocket expense. This has been a barrier to some patients trying medical cannabis as an alternative. Recruitment and inclusion/exclusion criteria: Potential participants will be recruited from an outpatient chronic pain clinic. 40 patients who have agreed to attempt wean down on opioid medication and have a diagnosis which qualifies them for medical marijuana will be selected for the study. In these selected patients, cost of the treatment was the main barrier for starting medical cannabis. Each participant will undergo a urine drug screen, a pain assessment using the visual analog scale and pain quality will be assessed using the Short Form-36 health related quality, prior to receiving medical cannabis. Each patient will have an individualized plan for weaning off their opioids which is their standard care plan. The patient will go to the select medical cannabis dispensary. The patient will be followed up monthly for five months by physician and will assess the patient's pain levels and Medical Cannabis doses and opioid doses monthly. The investigators will also note the patient side effects, tolerance and any decrease in symptoms. At five months the physician will recheck a urine drug screen, current pain level and readminister the Short form-36 health related quality. The Medical Cannabis doses and strains will be noted.
Interventions
- OTHER We will monitor patient's response to medical marijuana as alternative to opioid for chronic pain.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2025-10-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07194928
The ClinicalTrials.gov registry entry for NCT07194928 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which We will monitor patient's response to medical marijuana as alternative to opioid for chronic pain. is the first listed.
NCT07194928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07194928 about?
NCT07194928 is a clinical study titled "Medical Cannabis as an Opiate Alternative". Medical Cannabis is very safe and a viable option for pain relief to improve patients and their family's quality of life. However, medical cannabis is not covered by insurance and is an out of pocket expense. This has been a barrier to some patients trying medical cannabis as an alternative. Recrui...
What is the current status of trial NCT07194928?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2024-09-01. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT07194928?
The interventions under investigation include: We will monitor patient's response to medical marijuana as alternative to opioid for chronic pain. (OTHER).
Who is sponsoring clinical trial NCT07194928?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.